-- Areva, Lufthansa, Novartis, UBS: European Equity Preview
-- B y   J o s e p h   C i o l l i
-- 2012-05-03T04:00:01Z
-- http://www.bloomberg.com/news/2012-05-02/areva-lufthansa-novartis-ubs-european-equity-preview.html
The following companies’ shares may
have unusual moves in  European (SXXP)  trading. Stock symbols are in
parentheses.  The Stoxx Europe 600 Index fell 0.4 percent to 257.39. The
 Stoxx 50 Index (SX5P)  decreased 0.4 percent to 2,406.08. The  Euro Stoxx
50 Index (SX5E) , a benchmark measure for nations using the euro,
declined 0.7 percent to 2,290.31.  Areva SA (AREVA)  : The largest nuclear reactor maker has
started a process to sell its nuclear radiation measurement unit
Canberra, three people with knowledge of the plans said. The
shares fell 2.8 percent to 12.85 euros.  Deutsche Lufthansa AG (LHA)  : Europe’s second-biggest
airline said its first-quarter loss widened as European
economies slowed and the cost of fuel and restructuring measures
weighed on earnings. The shares gained 0.8 percent to 9.91
euros.  Eni SpA (ENI)  : Italy’s largest oil company said it
resumed operations at its Venice refinery following a six-month
halt. The shares dropped 0.7 percent to 16.65 euros.  Novartis AG (NOVN)  : Europe’s largest drugmaker said it
will purchase closely held Fougera Pharmaceuticals for $1.5
billion in a deal to gain generic skin medications. Fougera,
based in Melville, New York, had sales of about $429 million in
2011. Novartis shares fell 0.7 percent to 49.72 Swiss francs.  UBS AG (UBSN)  : Switzerland’s biggest bank was raised to
hold from sell at Deutsche Bank AG. The shares increased 3.7
percent to 11.75 Swiss francs.  To contact the reporter on this story:
Joseph Ciolli in  New York  at 
 jciolli@bloomberg.net   To contact the editor responsible for this story:
Michael P. Regan at 
 mregan12@bloomberg.net  